- Home
- ACR vs SGMO Comparison
ACR vs SGMO Comparison
Compare ACR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- SGMO
- Stock Information
- Founded
- ACR 2005
- SGMO 1995
- Country
- ACR United States
- SGMO United States
- Employees
- ACR N/A
- SGMO N/A
- Industry
- ACR Real Estate Investment Trusts
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACR Real Estate
- SGMO Health Care
- Exchange
- ACR Nasdaq
- SGMO Nasdaq
- Market Cap
- ACR 139.0M
- SGMO 122.8M
- IPO Year
- ACR N/A
- SGMO 2000
- Fundamental
- Price
- ACR $19.26
- SGMO $0.56
- Analyst Decision
- ACR Buy
- SGMO Buy
- Analyst Count
- ACR 2
- SGMO 6
- Target Price
- ACR $17.50
- SGMO $4.50
- AVG Volume (30 Days)
- ACR 29.4K
- SGMO 5.9M
- Earning Date
- ACR 07-30-2025
- SGMO 08-12-2025
- Dividend Yield
- ACR N/A
- SGMO N/A
- EPS Growth
- ACR N/A
- SGMO N/A
- EPS
- ACR 0.34
- SGMO N/A
- Revenue
- ACR $83,545,000.00
- SGMO $63,756,000.00
- Revenue This Year
- ACR $3.57
- SGMO $1.29
- Revenue Next Year
- ACR N/A
- SGMO $1.60
- P/E Ratio
- ACR $57.36
- SGMO N/A
- Revenue Growth
- ACR 6.92
- SGMO 239.92
- 52 Week Low
- ACR $14.40
- SGMO $0.41
- 52 Week High
- ACR $23.81
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ACR 61.49
- SGMO 54.90
- Support Level
- ACR $18.61
- SGMO $0.50
- Resistance Level
- ACR $19.22
- SGMO $0.70
- Average True Range (ATR)
- ACR 0.48
- SGMO 0.05
- MACD
- ACR 0.15
- SGMO 0.00
- Stochastic Oscillator
- ACR 80.23
- SGMO 39.83
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.